By targeting these pathways, we can develop therapies that not only suppress viral replication but also offer a functional cure for chronic hepatitis B," he said. The implications of this review are ...

There are now a number of other drugs in the same class in different stages of development, which have been shown to be even more potent inhibitors of hepatitis B replication. The large experience ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

For many people, the immune system is able to take control over the virus and they produce antibodies to one of the proteins of hepatitis B called ‘e’-antigen (or HBeAg). The amount of viral ...

Despite numerous treatment advances, chronic hepatitis B virus (HBV) infection remains ... an immune system response and suppressing viral replication to protect healthy hepatocytes may result ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of hepatitis B virus reactivation (HBVr) in at-risk persons. The document ...